Imaging News

Compared with controls, survivors of acute COVID-19 have elevated CV risks and burdens at 1 year, even if they were not hospitalized for COVID-19, researchers reported in Nature Medicine.

In patients with critical limb ischemia, CT-derived fractional flow reserve often detected silent coronary ischemia, and selective revascularization of those diagnosed with it improved outcomes, according to a presentation.

The virtual 2022 American College of Cardiology Scientific Session will be held from April 2 to 4, and will feature 25 late-breaking clinical trials, 10 featured clinical research presentations and numerous abstract presentations.

Magnetically controlled capsule endoscopy to identify gastrointestinal injury in patients taking antiplatelet therapy after PCI.

Most pediatric patients with multisystem inflammatory syndrome also had evidence of myocardial injury, but functional recovery was quick with no adverse coronary outcomes, researchers reported.

Healio and Cardiology Today have aggregated a list of recent updates on the CV impact of COVID-19 infection and vaccination.

Baseline aortic valve calcification was the most significant factor for calcium progression overall, but hypertension and dyslipidemia were the strongest predictors of aortic valve calcium progression among women and men, respectively.

CVD leads to approximately 40% to 50% of deaths in patients with advanced chronic kidney disease or end-stage renal disease, so CV risk assessment of recipients and donors is an important part of the kidney transplantation process.

A score derived from machine learning that included information from stress cardiac magnetic resonance effectively predicted 10-year all-cause death in patients with known or suspected CAD, researchers reported at EuroEcho 2021.

As the COVID-19 pandemic continued to dominate the news, more was learned about its CV implications over the past year. However, the year also featured a number of important developments in other realms of cardiology.